Claudicating patients with peripheral artery disease have meaningful improvement in walking speed after supervised exercise therapy



      Supervised exercise therapy (SET) is a first-line treatment for patients with peripheral artery disease (PAD). The efficacy of SET is most commonly expressed by significant statistical improvement of parameters that do not clarify how each individual patient will benefit from SET. This study examined the minimal clinically important difference (MCID) in walking speed in claudicating patients with PAD after SET.


      A total of 63 patients with PAD-related claudication (Fontaine stage II PAD) participated in a 6-month SET program. Self-selected walking speed was measured before and after SET. Distribution and anchor-based approaches were used to estimate the MCID for small and substantial improvement. The ability to walk one block and the ability to climb one flight of stairs questions were chosen as anchor questions from the Medical Outcomes Study 36-item Short Form questionnaire. Receiver operating characteristics curve analyses were performed to detect the threshold for MCID in walking speed after treatment.


      The distribution-based method estimated 0.03 m/s as a small improvement and 0.08 m/s as a substantial improvement after SET. Small and substantial improvements according to the anchor question walking one block were 0.05 m/s and 0.15 m/s, respectively. For the climbing one flight of stairs anchor question, 0.10 m/s was a small improvement. Receiver operating characteristics curve analyses identified an increase of 0.04 m/s and 0.03 m/s for improvement based on walking one block and climbing one flight of stairs, respectively.


      We report our findings for the MCID for walking speed among claudicating patients receiving SET. Claudicating patients who increase walking speed of 0.03 m/s or greater are more likely to experience a meaningful improvement in walking impairment than those who do not. The MCID reported in this study can serve as a benchmark for clinicians to develop goals and interpret clinically meaningful progress in the care of claudicating patients with PAD.

      Graphical abstract


      To read this article in full you will need to make a payment
      SVS Member Login
      Society Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Schieber M.N.
        • Pipinos II,
        • Johanning J.M.
        • Casale G.P.
        • Williams M.A.
        • DeSpiegelaere H.K.
        • et al.
        Supervised walking exercise therapy improves gait biomechanics in patients with peripheral artery disease.
        J Vasc Surg. 2020; 71: 575-583
        • Regensteiner J.G.
        • Steiner J.F.
        • Hiatt W.R.
        Exercise training improves functional status in patients with peripheral arterial disease.
        J Vasc Surg. 1996; 23: 104-115
        • Hiatt W.R.
        • Regensteiner J.G.
        • Hargarten M.E.
        • Wolfel E.E.
        • Brass E.P.
        Benefit of exercise conditioning for patients with peripheral arterial disease.
        Circulation. 1990; 81: 602-609
        • Patel K.
        • Polonsky T.S.
        • Kibbe M.R.
        • Guralnik J.M.
        • Tian L.
        • Ferrucci L.
        • et al.
        Clinical characteristics and response to supervised exercise therapy in people with lower extremity peripheral artery disease.
        J Vasc Surg. 2021; 73: 608-625
        • McDermott M.M.
        • Kibbe M.R.
        • Guralnik J.M.
        • Ferrucci L.
        • Criqui M.H.
        • Domanchuk K.
        • et al.
        Durability of benefits from supervised treadmill exercise in people with peripheral artery disease.
        JAHA. 2019; 8: e009380
        • Murphy T.P.
        • Cutlip D.E.
        • Regensteiner J.G.
        • Mohler 3rd, E.R.
        • Cohen D.J.
        • Reynolds M.R.
        • et al.
        Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study.
        J Am Coll Cardiol. 2015; 65: 999-1009
        • Jaeschke R.
        • Singer J.
        • Guyatt G.H.
        Measurement of health status. Ascertaining the minimal clinically important difference.
        Control Clin Trials. 1989; 10: 407-415
        • Gardner A.W.
        • Montgomery P.S.
        • Wang M.
        Minimal clinically important differences in treadmill, 6-minute walk, and patient-based outcomes following supervised and home-based exercise in peripheral artery disease.
        Vasc Med. 2018; 23: 349-357
        • Tilson J.K.
        • Sullivan K.J.
        • Cen S.Y.
        • Rose D.K.
        • Koradia C.H.
        • Azen S.P.
        • et al.
        Meaningful gait speed improvement during the first 60 days poststroke: minimal clinically important difference.
        Phys Ther. 2010; 90: 196-208
        • Middleton A.
        • Fritz S.L.
        • Lusardi M.
        Walking speed: the functional vital sign.
        J Aging Phys Act. 2015; 23: 314-322
        • Frans F.A.
        • Nieuwkerk P.T.
        • Met R.
        • Bipat S.
        • Legemate D.A.
        • Reekers J.A.
        • et al.
        Statistical or clinical improvement? Determining the minimally important difference for the vascular quality of life questionnaire in patients with critical limb ischemia.
        Eur J Vasc Endovasc Surg. 2014; 47: 180-186
        • Conijn A.P.
        • Jonkers W.
        • Rouwet E.V.
        • Vahl A.C.
        • Reekers J.A.
        • Koelemay M.J.W.
        Introducing the concept of the minimally important difference to determine a clinically relevant change on patient-reported outcome measures in patients with intermittent claudication.
        Cardiovasc Intervent Radiol. 2015; 38: 1112-1118
        • Conijn A.P.
        • Bipat S.
        • Reekers J.A.
        • Koelemay M.J.W.
        Determining the minimally important difference for the VascuQol sumscore and its domains in patients with intermittent claudication.
        Eur J Vasc Endovasc Surg. 2016; 51: 550-556
        • Nordanstig J.
        • Pettersson M.
        • Morgan M.
        • Falkenberg M.
        • Kumlien C.
        Assessment of minimum important difference and substantial clinical benefit with the vascular quality of life questionnaire-6 when evaluating revascularisation procedures in peripheral arterial disease.
        Eur J Vasc Endovasc Surg. 2017; 54: 340-347
        • Myers S.A.
        • Johanning J.M.
        • Stergiou N.
        • Lynch T.G.
        • Longo G.M.
        • Pipinos II,
        Claudication distances and the Walking Impairment Questionnaire best describe the ambulatory limitations in patients with symptomatic peripheral arterial disease.
        J Vasc Surg. 2008; 47: 550-555
        • Le Faucheur A.
        • Abraham P.
        • Jaquinandi V.
        • Bouyé P.
        • Saumet J.L.
        • Noury-Desvaux B.
        Measurement of walking distance and speed in patients with peripheral arterial disease.
        Circulation. 2008; 117: 897-904
        • Alley D.E.
        • Hicks G.E.
        • Shardell M.
        • Hawkes W.
        • Miller R.
        • Craik R.L.
        • et al.
        Meaningful improvement in gait speed in hip fracture recovery.
        J Am Geriatr Soc. 2011; 59: 1650-1657
        • Palombaro K.
        • Craik R.
        • Mangione K.
        • Tomlinson J.
        Determining meaningful changes in gait speed after hip fracture.
        Phys Ther. 2006; 86: 809-816
        • Foucher K.C.
        Identifying clinically meaningful benchmarks for gait improvement after total hip arthroplasty.
        J Orthop Res. 2016; 34: 88-96
        • Fulk G.D.
        • Ludwig M.
        • Dunning K.
        • Golden S.
        • Boyne P.
        • West T.
        Estimating clinically important change in gait speed in people with stroke undergoing outpatient rehabilitation.
        J Neurol Phys Ther. 2011; 35: 82-89
        • Kon S.S.C.
        • Canavan J.L.
        • Nolan C.M.
        • Clark A.L.
        • Jones S.E.
        • Cullinan P.
        • et al.
        The 4-metre gait speed in COPD: responsiveness and minimal clinically important difference.
        Eur Respir J. 2014; 43: 1298-1305
        • Hass C.J.
        • Bishop M.
        • Moscovich M.
        • Stegemöller E.L.
        • Skinner J.
        • Malaty I.A.
        • et al.
        Defining the clinically meaningful difference in gait speed in persons with Parkinson disease.
        J Neurol Phys Ther. 2014; 38: 233-238
        • Regensteiner J.
        • Hiatt W.
        Exercise in the management of peripheral artery disease. ACSM’s resource anual for guidelines for exercise testing and prescription.
        4th ed. Lippincott Williams & Wilkins, Philadelphia (PA)2001
        • American College of Sports M
        ACSM’s guidelines for exercise testing and prescription.
        9th ed. Lippincott Williams & Wilkins, Philadelphia (PA)2013
        • Wurdeman S.R.
        • Koutakis P.
        • Myers S.A.
        • Johanning J.M.
        • Pipinos II,
        • Stergiou N.
        Patients with peripheral arterial disease exhibit reduced joint powers compared to velocity-matched controls.
        Gait Posture. 2012; 36: 506-509
        • McCamley J.D.
        • Cutler E.L.
        • Schmid K.K.
        • Wurdeman S.R.
        • Johanning J.M.
        • Pipinos II,
        • et al.
        Gait mechanics differences between healthy controls and patients with peripheral artery disease after adjusting for gait velocity, stride length, and step width.
        J Appl Biomech. 2019; 35: 19-24
        • Perera S.
        • Mody S.H.
        • Woodman R.C.
        • Studenski S.A.
        Meaningful change and responsiveness in common physical performance measures in older adults.
        J Am Geriatr Soc. 2006; 54: 743-749
        • Akobeng A.K.
        Understanding diagnostic tests 3: receiver operating characteristic curves.
        Acta Paediatr Int J Paediatr. 2007; 96: 644-647
        • Bruce S.L.
        • Wilkerson G.B.
        Clinical prediction rules, part 1: conceptual overview.
        Athl Ther Today. 2010; 15: 4-9
        • Bohannon R.W.
        • Glenney S.S.
        Minimal clinically important difference for change in comfortable gait speed of adults with pathology: a systematic review.
        J Eval Clin Pract. 2014; 20: 295-300
        • Bohannon R.W.
        Comfortable and maximum walking speed of adults aged 20-79 years: reference values and determinants.
        Age Ageing. 1997; 26: 15-19
        • Paltamaa J.
        • Sarasoja T.
        • Leskinen E.
        • Wikström J.
        • Mälkiä E.
        Measuring deterioration in international classification of functioning domains of people with multiple sclerosis who are ambulatory.
        Phys Ther. 2008; 88: 176-190
        • Gras L.Z.
        • Kanaan S.F.
        • McDowd J.M.
        • Colgrove Y.M.
        • Burns J.
        • Pohl P.S.
        Balance and gait of adults with very mild Alzheimer disease.
        J Geriatr Phys Ther. 2015; 38: 1-7
        • Van Hedel H.J.A.
        • Wirz M.
        • Curt A.
        Improving walking assessment in subjects with an incomplete spinal cord injury: responsiveness.
        Spinal Cord. 2006; 44: 352-356
        • Van Den Houten M.M.L.
        • Gommans L.N.M.
        • Van Der Wees P.J.
        • Teijink J.A.W.
        Minimally important difference of the absolute and functional claudication distance in patients with intermittent claudication.
        Eur J Vasc Endovasc Surg. 2016; 51: 404-409
        • MejiaCruz Y.
        • Franco J.
        • Hainline G.
        • Fritz S.
        • Jiang Z.
        • Caicedo J.M.
        • et al.
        Walking speed measurement technology: a review.
        Curr Geriatr Reports. 2021; 10: 32-41
        • Morey M.C.
        • Ryan S.
        • Kelly J.
        • Liu C.
        • Hawkins K.
        • Schwartz K.
        • et al.
        The 6th vital sign: A mobile app for population health surveillance of walking speed.
        Innov Aging. 2017; 1: 669
        • Silsupadol P.
        • Teja K.
        • Lugade V.
        Reliability and validity of a smartphone-based assessment of gait parameters across walking speed and smartphone locations: body, bag, belt, hand, and pocket.
        Gait Posture. 2017; 58: 516-522
        • Lantz B.
        The large sample size fallacy.
        Scand J Caring Sci. 2013; 27: 487-492